“immunotherapy” Archives

in
Entry Author Date Location
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest 11/14/17 Boston
Juno Dissects ROCKET Deaths, Will Aim Better CAR-T at Leukemia 11/10/17 Seattle
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug 10/23/17 Boston
Xconomy Young Innovator Award Winner Armon Sharei—CEO Before 30 10/23/17 Boston
Kite Nabs First Adult CAR-T Approval With Notable Uptick Of Cures 10/18/17 National
Five Questions For … Austin Biotech Entrepreneur Paul Lammers 09/29/17 Texas
Check Out What’s Hot in Bay Area Biotech on December 6 09/14/17 San Francisco
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More 09/08/17 National
Bio Roundup: CAR-T’s Huge Week, Merck’s ‘Pib Choice & More 09/01/17 National
To Be More Than Quick Splash, Gilead’s CAR-T Purchase Faces Hurdles 08/28/17 San Francisco
Latest Immunotherapy Setback: Bristol Drugs Stumble in Kidney Cancer 08/16/17 New York
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 07/27/17 National
Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups 07/26/17 San Francisco
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs 07/25/17 San Diego
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer 07/24/17 Boston
Bio Roundup: BCRA Fireworks, Shkreli Muzzled, Endo Pulls Drug & More 07/07/17 National
FDA Halts Merck’s Multiple Myeloma Trials After Patient Deaths 07/05/17 New York
Acer Therapeutics Announces Reverse Merger With Houston’s Opexa 07/05/17 Texas
Boston Is Arguably the Heart of Biotech. But Who Makes It So? Have Your Say. 06/26/17 Boston
Bio Roundup: Trumpcare Is Mean, SCOTUS Says Go, Merck’s Myeloma No 06/16/17 National
In a Myeloma Setback, Merck Halts Studies Due to Patient Deaths 06/12/17 New York
Dragonfly, Tyler Jacks’s Disney-Backed Startup, Gets $33M in Celgene Deal 06/12/17 Boston
ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity 06/06/17 National
Bio Roundup: ASCO Combo Frenzy, Maine’s Free DNA Tests, Sema4 & More 06/02/17 National
On ASCO’s Eve, Experts Fret Over Backlash to Cancer Combo Frenzy 05/30/17 National
FDA Landmark Nod: Cancer Drug To Match Tumor Genes, Not Tissue Type 05/23/17 National
Page 1 of 6 next page »